REVB · Revelation Biosciences, Inc. · Held by Funds
$0.76
-0.04 (-4.67%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not anticipate that our current cash and cash equivalents balance will be sufficient to sustain operations within one year after the date that our unaudited financial statements for June 30, 2026 were issued, which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$3.47M
Shares
3.98M
Volume · Oct 2
43.9K
Avg daily vol (3M)
39.06K
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding REVB
2 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | FSMAX | 42,373 | $46,610 | 0.00% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 50 | $52 | 0.00% | Long | 2026-06-30 |
Showing 1–2 of 2 positions